Biogen Inc. buy Morgan Stanley
Start price
10.11.23
/
50%
€209.00
Target price
10.11.24
€349.02
Performance (%)
-22.34%
End price
11.11.24
€162.30
Summary
This prediction ended on 11.11.24 with a price of €162.30. The prediction for Biogen Inc. disappointed with a performance of -22.34%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -2.015% | -2.015% | 4.219% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by Morgan_Stanley for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Morgan Stanley from $361.00 to $373.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten